Translational Oncology

Article	Citations
Commentary: Machine learning developed an intratumor heterogeneity signature for predicting prognosis and immunotherapy benefits in cholangiocarcinoma	1554
The double face of cold in cancer	112
Comment on: AI-supported modified risk staging for multiple myeloma cancer useful in real-world scenario	103
GSDME has prognostic and immunotherapeutic significance in residual hepatocellular carcinoma after insufficient radiofrequency ablation	100
Interplay between Caveolin-1 and body and tumor size affects clinical outcomes in breast cancer	83
NCI's publication affiliation conundrum: Reframing innovation to incentivize an equitable path for advocate representation	78
Clinical characteristics and treatment efficacy of immune checkpoint inhibitors (ICIs) in patients with ICIs-induced Adrenal insufficiency	73
Detection of oncogenic mutations in paired circulating tumor DNA and circulating tumor cells in patients with hepatocellular carcinoma	70
A novel telomerase-derived peptide GV1001-mediated inhibition of angiogenesis: Regulation of VEGF/VEGFR-2 signaling pathways	67
Predictive value of peripheral blood leukocytes-based methylation of Long non-coding RNA MALAT1 and H19 in the chemotherapy effect and prognosis of gastric cancer	57
68Ga-PSMA11 PET/CT for biochemically recurrent prostate cancer: Influence of dual-time and PMT- vs SiPM-based detectors	54
FUBP1 in human cancer: Characteristics, functions, and potential applications	52
miR-1182-mediated ALDH3A2 inhibition affects lipid metabolism and progression in ccRCC by activating the PI3K-AKT pathway	51
ERβ-regulated circATP2B1/miR-204–3p/TWIST1 positive feedback loop facilitates epithelial to mesenchymal transition in clear cell renal cell carcinoma	51
Predicting lymphoma prognosis using machine learning-based genes associated with lactylation	49
Diagnostic assessment of deep learning for melanocytic lesions using whole-slide pathological images	49
Association of PIK3CA mutation with outcomes in HER2-positive breast cancer treated with anti-HER2 therapy: A meta-analysis and bioinformatic analysis of TCGA‑BRCA data	48
Hypericin mediated photodynamic therapy induces ferroptosis via inhibiting the AKT/mTORC1/GPX4 axis in cholangiocarcinoma	48
OLFM4 depletion sensitizes gallbladder cancer cells to cisplatin through the ARL6IP1/caspase-3 axis	46
Single-treatment tumor ablation with photodynamic liposomal irinotecan sucrosulfate	44
Identification of IMPA2 as the hub gene associated with colorectal cancer and liver metastasis by integrated bioinformatics analysis	43
Chlorogenic acid: Potential source of natural drugs for the therapeutics of fibrosis and cancer	42
Integrated multi-omics demonstrates enhanced antitumor efficacy of donafenib combined with FADS2 inhibition in hepatocellular carcinoma	42
Evolutionary dynamics of cancer multidrug resistance in response to olaparib and photodynamic therapy	42
XIAP overexpressing inflammatory breast cancer patients have high infiltration of immunosuppressive subsets and increased TNFR1 signaling targetable with Birinapant	42

Corrigendum to “Genomic profiles and their relationships with clinical characteristics and immune features in cervical cancer” [Translational Oncology 44 (2024) 1–10/101923]	41
Pan-cancer analysis of super-enhancer-induced LINC00862 and validation as a SIRT1-promoting factor in cervical cancer and gastric cancer	41
Radiation from frequent whole-body CT scans induces systemic immunosuppression and immune activation of tumor tissue	41
Loss of p53 epigenetically modulates epithelial to mesenchymal transition in colorectal cancer	40
A Novel Epigenetic Strategy to Concurrently Block Immune Checkpoints PD-1/PD-L1 and CD155/TIGIT in Hepatocellular Carcinoma	40
The Potential Role of C4 MYH11+ Fibroblasts and the MDK-SDC2 Ligand-Receptor Pair in Lung Adenocarcinoma: Implications for Prognosis and Therapeutic Strategies	38
ALYREF associated with immune infiltration is a prognostic biomarker in hepatocellular carcinoma	37
Connexin43 is associated with the progression of clear cell renal carcinoma and is regulated by tangeretin to sygergize with tyrosine kinase inhibitors	37
Anti-PD-1/PD-L1 therapy for colorectal cancer: Clinical implications and future considerations	36
Tumor treating fields: An emerging treatment modality for thoracic and abdominal cavity cancers	36
LncRNA DGUOK-AS1 facilitates non-small cell lung cancer growth and metastasis through increasing TRPM7 stability via m6A modification	35
CD44 occurring alternative splicing promotes cisplatin resistance and evokes tumor immune response in oral squamous cell carcinoma cells	35
Prediction of chemotherapy response in breast cancer patients at pre-treatment using second derivative texture of CT images and machine learning	35
Identification of metastasis-associated exoDEPs in colorectal cancer using label-free proteomics	34
Radiomic models for lymph node metastasis prediction in cervical cancer: can we think beyond sentinel lymph node?	33
CDYL loss promotes cervical cancer aggression by increasing PD-L1 expression via the suppression of IRF2BP2 transcription	33
Amivantamab and Mobocertinib in Exon 20 insertions EGFR Mutant Lung Cancer, Challenge To The Current Guidelines	33
Acetophenone protection against cisplatin-induced end-organ damage	32
Semaphorin 6D as an independent predictor for better prognosis in clear cell renal cell carcinoma	32
Retinol-binding protein 4 as a promising serum biomarker for the diagnosis and prognosis of hepatocellular Carcinoma	31
Single-cell insights into HNSCC tumor heterogeneity and programmed cell death pathways	31
Parathyroid hormone related protein (PTHrP) in patients with pancreatic carcinoma and overt signs of disease progression and host tissue wasting	31
Intratumoral heterogeneity after targeted therapy in murine cancer models with differing degrees of malignancy	31
Nuclear protein in testis carcinoma of the lung	30
Prognostication of colorectal cancer liver metastasis by CE-based radiomics and machine learning	30
MAZ-mediated tumor progression and immune evasion in hormone receptor-positive breast cancer: Targeting tumor microenvironment and PCLAF+ subtype-specific therapy	29
Nanoscale biomaterials for terahertz imaging: A non-invasive approach for early cancer detection	29
Currents status of radiotracers for breast cancer imaging in PET	28
Glutamine withdrawal leads to the preferential activation of lipid metabolism in metastatic colorectal cancer	28
Three-dimensional organoid culture unveils resistance to clinical therapies in adult and pediatric glioblastoma	28
Multiphase enhanced CT-based transformer for differential diagnosis and predicting surgical risk events of solid abdominal tumors in children	28
Graphene therapy-related lncRNAs as prognostic and immune microenvironmental biomarkers in hepatocellular carcinoma	28
Exploration of the mechanism of 5-Methylcytosine promoting the progression of hepatocellular carcinoma	28
Low expression of ZHX3 is associated with progression and poor prognosis in colorectal cancer	28
Identification and validation of autophagy-related prognostic signature for head and neck squamous cell carcinoma	27
Assessment of targeted therapy opportunities in sinonasal cancers using patient-derived functional tumor models	27
Selenium binding protein 1 inhibits tumor angiogenesis in colorectal cancers by blocking the Delta-like ligand 4/Notch1 signaling pathway	27
E2F2 serves as an essential prognostic biomarker and therapeutic target for human renal cell carcinoma by presenting “E2F2/miR-16–5p/SPTLC1” schema	27
NKp44-based chimeric antigen receptor effectively redirects primary T cells against synovial sarcoma	27
Individualized prognosis stratification in muscle invasive bladder cancer: A pairwise TP53-derived transcriptome signature	26
Liposomal sodium clodronate mitigates radiation-induced lung injury through macrophage depletion	26
Collagen modifying enzyme P4HA1 is overexpressed and plays a role in lung adenocarcinoma	25
CT radiomics combined with clinical variables for predicting the overall survival of hepatocellular carcinoma patients after hepatectomy	25
miR-362-3p suppresses ovarian cancer by inhibiting LRP8	25
Single-cell RNA sequencing to characterize the response of pancreatic cancer to anti-PD-1 immunotherapy	25
A multi-institutional observational study evaluating the incidence and the clinicopathological characteristics of NeoRAS wild-type metastatic colorectal cancer	25
Combining Mitomycin C with inhibition of BAD phosphorylation enhances apoptotic cell death in advanced cervical cancer	25
PRRX2 predicts poor survival prognosis, and promotes malignant phenotype of lung adenocarcinoma via transcriptional activates PSMD1	24
Systemic immune-inflammation index predicts survival in patients with resected lung invasive mucinous adenocarcinoma	24
Remote controlling of CAR-T cells and toxicity management: Molecular switches and next generation CARs	24

Matrix stiffness induces an invasive-dormant subpopulation via cGAS-STING axis in oral cancer	24
Generation of a competing endogenous RNA network and validation of BNIP1 expression in the lung of irradiated mice	23
ViBiBa: Virtual BioBanking for the DETECT multicenter trial program - decentralized storage and processing	23
Bazedoxifene inhibits sustained STAT3 activation and increases survival in GBM	23
Identification of leucine-rich repeat-containing protein 59 (LRRC59) located in the endoplasmic reticulum as a novel prognostic factor for urothelial carcinoma	22
Patient-derived tumor organoids: A preclinical platform for personalized cancer therapy	22
Beyond first-line therapy: efficacy and safety outcomes of continuing immunotherapy in extensive stage small cell lung cancer after PD-L1 inhibitor progression	22
M2-like tumor-associated macrophages may promote tumor progression in malignant pleural mesothelioma	22
Single-cell RNA sequencing integrated with bulk RNA sequencing analysis of clock circadian regulator with prognostic and immune microenvironment in thyroid cancer	22
Combined anti-leukemic effect of gilteritinib and GSK-J4 in FLT3-ITD+ acute myeloid leukemia	22
poly(I:C) synergizes with proteasome inhibitors to induce apoptosis in cervical cancer cells	22
Migration and invasion of NSCLC suppressed by the downregulation of Src/focal adhesion kinase using single, double and tetra domain anti- CEACAM6 antibodies	22
Improved survival of patients with stage III small-cell lung cancer with primary resection: A SEER-based analysis	21
Uncarboxylated osteocalcin induced miR-143-3p targets SP7 and activates PI3K/Akt signaling in TNBC cells to promote invasion and migration	21
LncRNA TCL6 regulates miR-876–5p/MYL2 axis to suppress breast cancer progression	21
Distinct molecular phenotype and the potential prognostic value of immune prognostic index and tumor infiltrating lymphocytes in hepatoid adenocarcinoma of stomach	21
The need for research targeting the link between occupational carcinogens and hepatopancreatobiliary cancers in Africa: A systematic review	20
A pan-cancer landscape of centromere proteins in tumorigenesis and anticancer drug sensitivity	20
Targeting sinonasal undifferentiated carcinoma with a combinatory immunotherapy approach	20
Comprehensive investigation in oncogenic functions and immunological roles of NCBP2 and its validation in prostate cancer	20
Targeting transcriptional kinase of CDK7 halts proliferation of multiple myeloma cells by modulating the function of canonical NF-kB pathway and cell cycle regulatory proteins	20
HIF1A predicts the efficacy of anti-PD-1 therapy in advanced clear cell renal cell carcinoma	20
Predominance of genomically defined A lineage of HPV16 over D lineage in Indian patients from eastern India with squamous cell carcinoma of the cervix in association with distinct oncogenic phenotypes	20
Hub genes in adenocarcinoma of the esophagogastric junction based on weighted gene co-expression network analysis and immunohistochemistry	20
RIPK2 and lysosomal pathway: Unveiling a new mechanism for lung cancer metastasis	20
CKAP4-mediated activation of FOXM1 via phosphorylation pathways regulates malignant behavior of glioblastoma cells	19
Fractionated radiation therapy alters energy metabolism and induces cellular quiescence exit in patient-derived orthotopic xenograft models of high-grade glioma	19
HSP90AA1 is an unfavorable prognostic factor for hepatocellular carcinoma and contributes to tumorigenesis and chemotherapy resistance	19
Tumor-stroma contact ratio - a novel predictive factor for tumor response to chemoradiotherapy in locally advanced oropharyngeal cancer	19
Comment on 'Long noncoding RNA UCA1 promotes glutamine-driven anaplerosis of bladder cancer by interacting with hnRNP I/L to upregulate GPT2 expression' by Chen et al.'”	19
Invasive phenotype in triple negative breast cancer is inhibited by blocking SIN3A–PF1 interaction through KLF9 mediated repression of ITGA6 and ITGB1	19
Utility of 18F-FDG uptake in predicting major pathological response to neoadjuvant immunotherapy in patients with resectable non‑small cell lung cancer	19
Integration of OV6 expression and CD68+ tumor-associated macrophages with clinical features better predicts the prognosis of patients with hepatocellular carcinoma	19
ENO1 promotes PDAC progression by inhibiting CD8+ T cell infiltration through upregulating PD-L1 expression via HIF-1α signaling	19
Myoepithelial carcinoma of major salivary glands: Analysis of population-based clinicopathologic and prognostic features	19
NPRA promotes fatty acid metabolism and proliferation of gastric cancer cells by binding to PPARα	18
Multi-omics profiling to identify early plasma biomarkers in pre-diagnostic pancreatic ductal adenocarcinoma: a nested case-control study	18
RNA-binding protein IGF2BP2 suppresses metastasis of clear cell renal cell carcinoma by enhancing CKB mRNA stability and expression	18
Spatial correlation between in vivo imaging and immunohistochemical biomarkers: A methodological study	18
Cancer is not a guest	18
Mechanisms of abemaciclib, a CDK4/6 inhibitor, induced apoptotic cell death in prostate cancer cells in vitro	18
Circling back to epigenetic regulation in osteosarcoma: Comment on ‘Hsa_circ_0088212-mediated miR-520h/APOA1 axis inhibits the osteosarcoma progression’ by ‘ Hao Peng’	18
GTF2H5 Identified as a crucial synthetic lethal target to counteract chemoresistance in colorectal cancer	18
Oncosuppressive role of MicroRNA-205–3p in gastric cancer through inhibition of proliferation and induction of senescence	17
PER3 suppresses tumor metastasis of oral squamous cell carcinoma by promoting HIF-1α degradation	17
Pan-cancer analysis of 60S Ribosomal Protein L7-Like 1 (RPL7L1) and validation in liver hepatocellular carcinoma	17
The relationship between URG4 and clinicopathologic parameters and its effect on two-year survival in gastric carcinoma	17
INHA acts as a novel and potential biomarker in lung adenocarcinoma and shapes the immune-suppressive tumor microenvironment	17
The interplay of pineal hormones and socioeconomic status leading to colorectal cancer disparity	17
High-resolution anoscopy predictive modeling of anal canal cancer response after definitive chemoradiotherapy in COVID19 era	17
Circular RNA 0010117 promotes aggressive glioblastoma behavior by regulating the miRNA-6779-5p/SPEN axis	17
TRIM37 promotes gallbladder cancer proliferation by activating the Wnt/β-catenin pathway via ubiquitination of Axin1	16
Discovering the Potential Role of the C2 DUSP2+ MCs Subgroup in Lung Adenocarcinoma	16
A retrospective cohort study of neoadjuvant chemoradiotherapy combined with immune checkpoint inhibitors in locally advanced rectal cancer	16
Transition metal ion-doped ferrites nanoparticles for bioimaging and cancer therapy	16
Peroxisome proliferator-activated receptors: Key regulators of tumor progression and growth	16
Cardiotoxicity of breast cancer drug treatments	16
Machine-learning based integrating bulk and single-cell RNA sequencing reveals the SLC38A5-CCL5 signaling as a promising target for clear cell renal cell carcinoma treatment	16
Radiosensitizing effects of CDK4/6 inhibitors in hormone receptor-positive and HER2-negative breast cancer mediated downregulation of DNA repair mechanism and NF-κB-signaling pathway	16
The remodelling of actin composition as a hallmark of cancer	16
Progress on carbon dots and hydroxyapatite based biocompatible luminescent nanomaterials for cancer theranostics	16
Exosomal circ50547 as a potential marker and promotor of gastric cancer progression via miR-217/HNF1B axis	16
Low levels of miR-34c in nasal washings as a candidate marker of aggressive disease in wood and leather exposed workers with sinonasal intestinal-type adenocarcinomas (ITACs)	16
Contribution of immune cells in synergistic anti-tumor effect of ablation and immunotherapy	16
Development and validation of a radiomic prediction model for TACC3 expression and prognosis in non-small cell lung cancer using contrast-enhanced CT imaging	16
LncRNA PSMB8-AS1 increases glioma malignancy via the miR-382-3p/BCAT1 axis	16
Corrigendum to < Rapid evaluation of T cell clonality in the diagnostic work-up of mature T cell neoplasms: TRBC1-based flow cytometric assay experience><Translational Oncology, 26C (2022) 10	15
A Commentary on: Long-term outcomes of induction chemotherapy followed by intensity modulated radiotherapy and adjuvant chemotherapy in nasopharyngeal carcinoma patients with N3 disease	15
The quest for ligands and binding partners of atypical cadherin FAT1	15
Increased tumor-infiltrating plasmacytoid dendritic cells express high levels of PD-L2 and affect CD8+ T lymphocyte infiltration in human laryngeal squamous cell carcinoma	15
Transcriptional regulation of DLGAP5 by AR suppresses p53 signaling and inhibits CD8+ T cell infiltration in triple-negative breast cancer	15
Design of a humanized CD40 agonist antibody with specific properties using AlphaFold2 and development of an anti-PD-L1/CD40 bispecific antibody for cancer immunotherapy	15
Anti-cancer effects of pyrazole-platinum(II) complexes combined with anti-MUC1 monoclonal antibody versus monotherapy in DLD-1 and HT-29 colon cancer cells	15
LCMT1 indicates poor prognosis and is essential for cell proliferation in hepatocellular carcinoma	15
Dysregulated proton and sodium gradients highlight cancer invasion and proliferation	15
Development and validation of a microenvironment-related prognostic model for hepatocellular carcinoma patients based on histone deacetylase family	15
Exploring the tumor-suppressive role of miRNA-200c in head and neck squamous cell carcinoma: Potential and mechanisms of exosome-mediated delivery for therapeutic applications	15
Diverse and converging roles of ERK1/2 and ERK5 pathways on mesenchymal to epithelial transition in breast cancer	15
USP8 regulates liver cancer progression via the inhibition of TRAF6-mediated signal for NF-κB activation and autophagy induction by TLR4	15
Immune-pyroptosis-related genes predict the prognosis of kidney renal clear cell carcinoma	15

Individualized tumor-reactive T cells exhibit a potent anti-tumor response in prostate cancer	14
Characterization of the mechanism of Scutellaria baicalensis on reversing radio-resistance in colorectal cancer	14
Integration RNA bulk and single cell RNA sequencing to explore the change of glycolysis-related immune microenvironment and construct prognostic signature in head and neck squamous cell carcinoma	14
Long non-coding RNA FENDRR suppresses cancer-associated fibroblasts and serves as a prognostic indicator in colorectal cancer	14
Timp2 loss-of-function mutation and TIMP2 treatment in a murine model of NSCLC: Modulation of immunosuppression and oncogenic signaling	14
lncRNA JPX modulates malignant progress of osteosarcoma through targeting miR-33a-5p and PNMA1 regulatory loop	14
Micro-hydrogel injectables that deliver effective CAR-T immunotherapy against 3D solid tumor spheroids	14
Development and validation of a prognostic and drug sensitivity model for gastric cancer utilizing telomere-related genes	14
Yi Shen Tiao Gan decoction alleviates aromatase inhibitor–related bone loss by promoting H-type vessel formation	14
Specific vaginal and gut microbiome and the anti-tumor effect of butyrate in cervical cancer women	14
Enhanced effect of radiofrequency ablation on HCC by siRNA-PD-L1-endostatin Co-expression plasmid delivered	14
Identification of novel prognostic indicators for oral squamous cell carcinoma based on proteomics and metabolomics	14
Dysregulation of peripheral and intratumoral KLRG1+ CD8+ T cells is associated with immune evasion in patients with non-small-cell lung cancer	14
Identification and validation of a prognostic risk model based on radiosensitivity-related genes in nasopharyngeal carcinoma	14
TRPC5 mediates TMZ resistance in TMZ-resistant glioblastoma cells via NFATc3-P-gp pathway	14
3D heterospecies spheroids of pancreatic stroma and cancer cells demonstrate key phenotypes of pancreatic ductal adenocarcinoma	14
Distinctive mesenchymal-like neurofibroma stem cells shape NF1 clinical phenotypes controlled by BDNF microenvironment	13
Clinicopathological characteristics of androgen receptor splicing variant 7 (AR-V7) expression in patients with castration resistant prostate cancer: A systematic review and meta‐analysis	13
TMEM180 contributes to SW480 human colorectal cancer cell proliferation through intra-cellular metabolic pathways	13
Therapeutic effects of an innovative BS-HH-002 drug on pancreatic cancer cells via induction of complete MCL-1 degradation	13
CCR9-CCL25 mediated plasmacytoid dendritic cell homing and contributed the immunosuppressive microenvironment in gastric cancer	13
A high-quality model for predicting the prognosis of breast neuroendocrine carcinoma to help clinicians decide on appropriate treatment methods: A population-based analysis	13
Response Gene to Complement 32 is associated with poor patient survival and an inflamed tumor-immune microenvironment in clear cell renal cell carcinoma	13
Tissue contexture determines the pattern and density of tumor-infiltrating immune cells in HPV-associated squamous cell carcinomas of oropharynx and uterine cervix	13
Exosomal mRNA Cargo are biomarkers of tumor and immune cell populations in pediatric osteosarcoma	13
Recommendations for extracellular vesicle miRNA biomarker research in the endometrial cancer context	13
A mini-review-cancer energy reprogramming on drug resistance and immune response	13
Renin-angiotensin system inhibitors combined with cisplatin exacerbate cisplatin-induced nephrotoxicity in mice	13
PTPN3 is a potential target for a new cancer immunotherapy that has a dual effect of T cell activation and direct cancer inhibition in lung neuroendocrine tumor	13
RPL36A activates ERK pathway and promotes colorectal cancer growth	13
Dual inhibition of BET and EP300 has antitumor activity in undifferentiated pleomorphic sarcomas and synergizes with ferroptosis induction	13
Predicting oncogene mutations of lung cancer using deep learning and histopathologic features on whole-slide images	13
Early onset pancreatic cancer: A review	13
Anti-epidermal growth factor receptor (EGFR) monoclonal antibody combined with chemoradiotherapy for induction chemotherapy resistant locally advanced nasopharyngeal carcinoma: A prospective phase II	13
Comprehensive characterization of immune landscape of Indian and Western triple negative breast cancers	13
PD-1 and TIGIT blockade differentially affect tumour cell survival under hypoxia and glucose deprived conditions in oesophageal adenocarcinoma; implications for overcoming resistance to PD-1 blockade	13
Beta-adrenergic pathway activation enhances aggressiveness and inhibits stemness in head and neck cancer	13
Tebentafusp in first-line melanoma trials: An outperforming outlier	13
The PI3K/Akt/mTOR pathway in lung cancer; oncogenic alterations, therapeutic opportunities, challenges, and a glance at the application of nanoparticles	13
Prolactin enhances T regulatory cell promotion of breast cancer through the long form prolactin receptor	13
Clinical significance of circulating tumor cells after chemotherapy in unresectable pancreatic ductal adenocarcinoma	13
Vaccine-induced ErbB (EGFR/HER2)-specific immunity in spontaneous canine cancer	13
Clinical significance of risk stratification of esophageal squamous cell carcinoma after neoadjuvant chemoradiation and surgery	13
Genomic profiles and their relationships with clinical characteristics and immune features in cervical cancer	13
RPS21 Enhances hepatocellular carcinoma development through GPX4 stabilization	13
Nuclear localization dictates hepatocarcinogenesis suppression by glycine N-methyltransferase	12
Construction and validation of a risk scoring model for diffuse large B-cell lymphoma based on ferroptosis-related genes and its association with immune infiltration	12
Charting new frontiers: Co-inhibitory immune checkpoint proteins in therapeutics, biomarkers, and drug delivery systems in cancer care	12
PIS as a regulator of cellular heterogeneity, prognostic significance, and immune landscape in thyroid cancer	12
ARID1A deficiency associated with MMR deficiency and a high abundance of tumor-infiltrating lymphocytes predicts a good prognosis of endometrial carcinoma	12
Saliva as a potential non-invasive liquid biopsy for early and easy diagnosis/prognosis of head and neck cancer	12
Preclinical evidence for employing MEK inhibition in NRAS mutated pediatric gastroenteropancreatic neuroendocrine-like tumors	12
RBM15 facilities lung adenocarcinoma cell progression by regulating RASSF8 stability through N6 Methyladenosine modification	12
HER2 as a potential therapeutic target on quiescent prostate cancer cells	12
miRNA patterns in male LUSC patients - the 3-way mirror: Tissue, plasma and exosomes	12
The predictive efficacy of tumor mutation burden in immunotherapy across multiple cancer types: A meta-analysis and bioinformatics analysis	12
A comprehensive review on recent advances in exosome isolation and characterization: Toward clinical applications	12
Hepatocellular cancer therapy in patients with HIV infection: Disparities in cancer care, trials enrolment, and cancer-related research	12
Systemic levels of the soluble co-inhibitory immune checkpoints, CTLA-4, LAG-3, PD-1/PD-L1 and TIM-3 are markedly increased in basal cell carcinoma	12
Comprehensive assessment of serum 3′-tRFArg as a novel diagnostic biomarker for gastric cancer	12
The molecular mechanism and challenge of targeting XPO1 in treatment of relapsed and refractory myeloma	12
Analysis of transition metal content in glioblastoma reveals association between iron and survival	12
Comprehensive analysis of protein post-translational modifications reveals PTPN2-STAT1-AOX axis-mediated tumor progression in hepatocellular carcinomas	12
The ATR inhibitor VE-821 increases the sensitivity of gastric cancer cells to cisplatin	12
Influence of cholesterol on cancer progression and therapy	12
PARP inhibitors and metastatic castration-resistant prostate cancer: uture directions and pitfalls	11
SnoRNA U50A mediates everolimus resistance in breast cancer through mTOR downregulation	11
Resonance of fatty acid metabolism and immune infiltration in anti-PD-1 monotherapy for breast cancer	11
Suppression of FAM83D Inhibits Glioma Proliferation, Invasion and Migration by Regulating the AKT/mTOR Signaling Pathway	11
Hypoxia induced cell dormancy of salivary adenoid cystic carcinoma through miR-922/DEC2 axis	11
Type of chemotherapy has substantial effects on the immune system in ovarian cancer	11
A prognostic signature consisting of N6-methyladenosine modified mRNAs demonstrates clinical potential in prediction of biochemical recurrence and guidance on precision therapy in prostate cancer	11
Adjuvant hypofractionated radiotherapy with simultaneous integrated boost after breast-conserving surgery: A systematic literature review	11
EGFR mutation testing from pleural effusions of non-small cell lung cancer patients at the institute for oncology and radiology of Serbia	11
A practical distribution pattern of α-SMA-positive carcinoma associated fibroblasts indicates poor prognosis of patients with pancreatic ductal adenocarcinoma	11
Enhancing chemotherapy response prediction via matched colorectal tumor-organoid gene expression analysis and network-based biomarker selection	11
Peripheral blood values as predictors of autoimmune status in oral cavity squamous cell carcinoma	11
Long noncoding RNA BBOX1-AS1 increased radiotherapy sensitivity in colorectal cancer by stabilizing and activating PFK1	11
Analysis of patient reported outcomes included in the registrational clinical trials of nivolumab for advanced non-small cell lung cancer	11
CDK4/6 inhibitors promote PARP1 degradation and synergize with PARP inhibitors in non-small cell lung cancer	11
Chondroitin sulfate proteoglycan 4, a targetable oncoantigen that promotes ovarian cancer growth, invasion, cisplatin resistance and spheroid formation	11
PRMT5 inhibitors: Therapeutic potential in pancreatic cancer	11
Application of predictive model based on CT radiomics and machine learning in diagnosis for occult locally advanced esophageal squamous cell carcinoma before treatment: A two-center study	11
Long noncoding RNAs and HPV-related cervical cancer: Uncovering molecular mechanisms and clinical applications	11
Corrigendum to “Exosomes in malignant pleural effusion from lung cancer patients impaired the cytotoxicity of double-negative T cells” [Translational Oncology 27 (2023) 1–9/101564]	11
SNF5, a core subunit of SWI/SNF complex, regulates melanoma cancer cell growth, metastasis, and immune escape in response to matrix stiffness	11
Clinical application of the 21-gene oncotype recurrence score in an older cohort: A single center experience	11
Clinical characteristics of EGFR-ctDNA shedders in EGFR-mutant NSCLC patients	11
Functional temozolomide sensitivity testing of patient-specific glioblastoma stem cell cultures is predictive of clinical outcome	11
KIAA1529 regulates RAD51 expression to confer PARP inhibitors resistance in ovarian cancer	11
Comment on: Endogenous retroviruses expressed in human tumours cannot be used as targets for anti-tumour vaccines	11
Genomic identification of sarcoma radiosensitivity and the clinical implications for radiation dose personalization	11
Ad-VT causes ovarian cancer A2780 cell death via mitochondrial apoptosis and autophagy pathways	11
Role of 3-mercaptopyruvate sulfurtransferase in cancer: Molecular mechanisms and therapeutic perspectives	11
Authors’ reply: Perspective: The approval and withdrawal of melphalan flufenamide (melflufen): Implications for the state of the FDA	10